
About NeuroVista
NeuroVista was a Consumer company based in Nottingham (United Kingdom) founded in 2002 by Daniel DiLorenzo. It operates as an online platform offering Toto Macau gambling registration and login. It operates on a B2C model. NeuroVista has raised $61.3 million across 4 funding rounds from investors including Credit Suisse, Cyberonics and NIHI. The company is recorded as dissolved. NeuroVista offers products and services including Toto Macau Platform. Its focus areas include Entertainment, Online Gaming, Betting and Toto Macau. Its competitors include AliveCor, iHealth Labs, Aktiia, Monitra Healthcare and Agatsa and 4 more; 8 of its 9 listed competitors have raised funding.
Company details
UNGUTOTO serves as a digital site for Agen Bandar Toto Macau, enabling users to register and access trusted togel betting in 2025. It focuses on online gambling activities, integrating with cultural guides and events in Manchester. The platform provides secure login and betting options, primarily targeting individual users in the UK for entertainment and wagering. It connects to local listings but centers on digital betting services.
- Headquarters Nottingham, United Kingdom
- Founders Daniel DiLorenzo
- SectorsConsumer
- Emailβ’β’β’β’β’β’β’β’
- Website neurovista.com
- Social X Facebook Instagram
- Total Equity Funding$61.3M (USD)
in 4 rounds
- InvestorsCredit Suisse
& 8 more
Products & Services of NeuroVista
NeuroVista offers a comprehensive portfolio of products and services, including Toto Macau Platform.
Service for user registration and gambling on Toto Macau games
Funding Insights of NeuroVista
NeuroVista has successfully raised a total of $61.3M across 4 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $61.3M
- Total Rounds 4
- First Round $33.8M
(May 2007)
- Investors Count 9
All 4 funding rounds of NeuroVista with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2012 | – | Series B | β | NIHI | β |
| Aug 2010 | $21.5M | Series B | β | GBS | |
| Oct 2009 | $6M | Series B | β | β | β |
| May 2007 | $33.8M | Series B | β | Advanced Technology Ventures, Delphi Ventures |
9 investors in total: 9 institutional.
Investors in NeuroVista
NeuroVista has secured backing from 9 investors, including institutional and venture fund investors. Prominent investors backing the company include Credit Suisse, Cyberonics and NIHI.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
VC firm making investment in early stage startups in the US | – | atvcapital.com | Menlo Park, United States | |
Investments are made in life sciences firms across all stages. | – | delphiventures.com | Menlo Park, United States | |
- | – | gbsventures.com.au | - | |
Early-stage tech startups are funded by this venture capital firm. | – | flarecapital.com | Boston, United States | |
Life science & tech focused VC firm investing in companies in the US | – | threearchpartners.com | San Mateo, United States | |
NIHI provides education, research, and community building in health informatics. | 2008 | nihi.ca | Waterloo, Canada | |
- | – | snhproviders.org | - | |
Vagus nerve stimulation therapy is developed for epilepsy and depression. | 1987 | cyberonics.com | Houston, United States | |
Wealth management, asset management, and investment banking services are offered. | 1856 | credit-suisse.com | Zurich, Switzerland |
Investor details for NeuroVista
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of NeuroVista
1 people are tracked at NeuroVista (1 in leadership).
| Name | Role | Group |
|---|---|---|
Daniel DiLorenzo | Founder | Leadership |
Complete people profiles for NeuroVista
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of NeuroVista
3 dated milestones of NeuroVista across 10 years, from founding to its latest funding, stage changes and deals.
- Founded NeuroVista is founded.
- Funding First funding round of $33.8M.
- Funding Latest funding round, Series B,.
Competitors of NeuroVista
NeuroVista has 9 listed competitors in our database, 8 of them funded. They include AliveCor, iHealth Labs, Aktiia, Monitra Healthcare and Agatsa, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| alivecor.com | 2010 | Mountain View, United States | $114.38M | 67 | Cardiac monitoring devices and applications are provided for heart health. | |
| ihealthlabs.com | 2010 | Mountain View, United States | $25M | 104 | Personal healthcare devices for vital monitoring are designed and produced. | |
| aktiia.com | 2018 | Neuchatel, Switzerland | – | – | Offers wearable technology for 24/7 blood pressure tracking and app-based data analysis. | |
| monitrahealth.com | 2016 | Hyderabad, India | $3.68M | 41 | Ambulatory cardiac monitoring devices and solutions | |
| agatsa.com | 2014 | Noida, India | $10.04M | 80 | Portable ECG devices and heart health monitors are manufactured. | |
| peerbridgehealth.com | 2012 | New York, United States | $66.14M | 3 | Wearable wireless ECG sensors for cardiac monitoring are developed. | |
| preventicesolutions.com | 2004 | Valley, United States | $137M | – | Cloud-based remote telemonitoring platforms are supplied to healthcare providers. | |
| profusa.com | 2009 | San Francisco, United States | $62.16M | 15 | Biochemical sensors are developed for real-time chronic disease monitoring. | |
| vectoriousmedtech.com | 2011 | Tel Aviv, Israel | $14.3M | – | Miniature wireless implant for left atrial pressure monitoring is provided. |
Detailed competitors of NeuroVista
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Gambling & Entertainment Platforms
10 companies that operate in the same segment as NeuroVista (Gambling & Entertainment Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Licensed sports merchandise, collectibles, and betting platforms are provided. | 2011 | New York, New York, United States | USD 4.85 B | – | 14,656 | |
Online skill-based games are developed across platforms and genres. | 2010 | Delhi, Delhi, India | USD 1.79 M | USD 166.95 M | 699 | |
Mobile casino games with social features are developed for platforms. | 2014 | Warsaw, Poland | USD 8.6 M | USD 246.28 M | 428 | |
An online platform for skill-based gaming competitions is provided. | 2019 | Gurugram, Haryana, India | USD 25.96 M | USD 11.28 M | 39 | |
Provider of online skill-based gaming platforms | 2005 | Hyderabad, Telangana, India | USD 81.87 M | USD 128.91 M | 529 | |
Developer of a micro-betting platform for sports | 2022 | Miami, Florida, United States | USD 102 M | – | – | |
Provider of a P2P sports betting platform | 2021 | New York, New York, United States | USD 75 M | – | 94 | |
Multi-category online gambling is facilitated via an app-based platform. | 1934 | London, England, United Kingdom | – | USD 1.71 B | 10,239 | |
Online platform for betting on multiple sports is provided. | 2001 | Stoke On Trent, England, United Kingdom | – | – | – | |
Casual mobile games are developed and published by SciPlay. | 2007 | London, England, United Kingdom | – | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Neurovista
Complete news archive for NeuroVista
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about NeuroVista
NeuroVista was founded in 2002 and raised its 1st funding round 5 years after it was founded.
NeuroVista is headquartered in Nottingham, United Kingdom.
NeuroVista is a funded company, having raised a total of $61.3M across 4 funding rounds to date. The company's 1st funding round was a Series B of $33.8M, raised on May 2007.
UNGUTOTO serves as a digital site for Agen Bandar Toto Macau, enabling users to register and access trusted togel betting in 2025. It focuses on online gambling activities, integrating with cultural guides and events in Manchester. The platform provides secure login and betting options, primarily targeting individual users in the UK for entertainment and wagering. It connects to local listings but centers on digital betting services.
NeuroVista's top competitors include AliveCor, iHealth Labs and Profusa.
NeuroVista offers Toto Macau Platform.
NeuroVista has 9 investors. Key investors include Credit Suisse, Cyberonics, NIHI, Advanced Technology Ventures, and Delphi Ventures.
